Clinical trial delays are a persistent bottleneck in healthcare innovation, a problem Cori Clinical aims to solve with its AI-guided platform. The startup, which provides an intelligence layer to accelerate trial start-up processes, has now secured $4.0M in seed funding from investors including Breega, Enzo, HEARTFELT_, Together Ventures, and Bynd.
Cori Clinical positions itself as a living blueprint for trials, transforming insights and organizational experience into a unified workspace for research, design, authoring, and review. Its AI-guided system drafts protocols and modifications, empowering clinical teams at leading biotechs, CROs, and research institutions to move faster and maintain quality without compromising compliance.


















